Evidence map›Paper›PMID 32880873›Full record

ReviewJournal of neurovirology2020

Studying the neuropsychological sequelae of SARS-CoV-2: lessons learned from 35 years of neuroHIV research.

Andrew Levine, Ned Sacktor, James T Becker

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of neurovirology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Andrew LevineDepartment of Neurology David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA. ajlevine@mednet.ucla.edu.ORCID 0000-0001-9683-1746
Ned SacktorDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
James T BeckerDepartments of Psychiatry, Neurology, and Psychology, University of Pittsburgh, Pittsburgh, PA, 15260, USA.
Johns Hopkins University · USUniversity of California, Los Angeles · USUniversity of Pittsburgh · US

Funding

University of Pittsburgh Multicenter AIDS Cohort Study (MACS)U01AI035041 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MARTINSON, JEREMY JAMES, RINALDO, CHARLES R · 1993 to 2018
$71.4M
Therapeutic CoreP30MH075673 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Barbara Stauch Slusher · 2006 to 2026
$33.2M
Cardiovascular and HIV/AIDS Effects on Brain Structure/Function and CognitionR01AG034852 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BECKER, JAMES T. · 2010 to 2020
$9.2M
Connectomics of Brain Aging and DementiaUF1AG051197 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BECKER, JAMES T. · 2016 to 2018
$6.2M
Bardoxolone: a novel treatment for HIV-associated neurocognitive disordersR21MH115825 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LEVINE, ANDREW J · 2018 to 2019
$444k
Causes and consequences of suboptimal cognitive effort in the MACSR03NS110476 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LEVINE, ANDREW J · 2018 to 2019
$156k
NIAID NIH HHS U01 AI035041NIA NIH HHS R01 AG034852NIA NIH HHS UF1 AG051197NIMH NIH HHS P30 MH075673NIMH NIH HHS R21 MH115825NINDS NIH HHS R03 NS110476
6 · The paper itself

Abstract

The virology of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and the human immune response to the virus are under vigorous investigation. There are now several reports describing neurological symptoms in individuals who develop coronavirus disease 2019 (COVID-19), the syndrome associated with SARS-CoV-2 infection. The prevalence, incidence, and clinical course of these symptoms will become clearer in the coming months and years through epidemiological studies. However, the long-term neurological and cognitive consequence of SARS-CoV-2 infection will remain conjectural for some time and will likely require the creation of cohort studies that include uninfected individuals. Considering the early evidence for neurological involvement in COVID-19 it may prove helpful to compare SARS-CoV-2 with another endemic and neurovirulent virus, human immunodeficiency virus-1 (HIV-1), when designing such cohort studies and when making predictions about neuropsychological outcomes. In this paper, similarities and differences between SARS-CoV-2 and HIV-1 are reviewed, including routes of neuroinvasion, putative mechanisms of neurovirulence, and factors involved in possible long-term neuropsychological sequelae. Application of the knowledge gained from over three decades of neuroHIV research is discussed, with a focus on alerting researchers and clinicians to the challenges in determining the cause of neurocognitive deficits among long-term survivors.

Indexed as

SARS-CoV-2AIDS Dementia ComplexCOVID-19HumansNervous System DiseasesCOVID-19HIV-associated neurocognitive disordersNeuroHIVNeuropsychologySARS-CoV-2

Identifiers

PMID32880873
PMCPMC7471564
OpenAlexW3082803683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.